PFIZER, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.4 USD | +0.55% |
|
-2.31% | -11.77% |
| 04-26 | S&P 500 Posts First Weekly Gain Since March as Tech, Consumer Discretionary Lead Rise on Better-Than-Expected Earnings | MT |
| 04-26 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
Chart calendar Pfizer, Inc.
689be6358133e7b3ceb56e3f0416b3.nfaCXSsauSTsocmgNOe-Up0koG9wUeTDzjHOiq1DRgM.yLvNJ0FQjWeay6zSeJ_rAs9j51xGE6CSuEGrx5ogdEDTjuEeRk_8e4n1mA~e40a430f02eadfedbd92552e67ebb4fa
Upcoming events on Pfizer, Inc.
Past events on Pfizer, Inc.
| 25/04/2024 14:00 | Annual General Meeting |
| 12/03/2024 12:00 | Leerink Partners Global Biopharma Conference |
| 04/03/2024 16:10 | TD Cowen Health Care Conference |
| 29/02/2024 18:00 | Investor Day - Oncology Innovation |
| 30/01/2024 15:00 | Q4 2023 Earnings Call |
| 30/01/2024 11:45 | Q4 2023 Earnings Release |
| 24/01/2024 | Ex-dividend day |
| 08/01/2024 23:00 | JPMorgan Healthcare Conference |
| 13/12/2023 13:30 | Q4 2024 Guidance Call |
| 12/12/2023 01:15 | American Society of Hematology Meeting - Abstract Number -1054 |
| 12/12/2023 00:30 | American Society of Hematology Meeting - Abstract Number -1057 |
| 10/12/2023 00:45 | American Society of Hematology Meeting - Abstract Number -274 |
| 10/12/2023 00:30 | American Society of Hematology Meeting - Abstract Number -285 |
| 09/12/2023 17:45 | American Society of Hematology Meeting - Abstract Number -14 |
| 28/11/2023 15:50 | Evercore ISI HealthCONx Conference |
| 09/11/2023 17:35 | Truist Securities Healthcare Conference |
| 08/11/2023 | Ex-dividend day |
| 31/10/2023 14:00 | Q3 2023 Earnings Call |
| 31/10/2023 10:45 | Q3 2023 Earnings Release |
| 16/10/2023 13:00 | Business Update Call |
Past dividends on Pfizer, Inc.
| 24/01/2024 | Quarterly 0.42 USD |
| 08/11/2023 | Quarterly 0.41 USD |
| 26/07/2023 | Quarterly 0.41 USD |
| 10/05/2023 | Quarterly 0.41 USD |
| 25/01/2023 | Quarterly 0.41 USD |
| 02/11/2022 | Quarterly 0.4 USD |
| 27/07/2022 | Quarterly 0.4 USD |
| 11/05/2022 | Quarterly 0.4 USD |
| 26/01/2022 | Quarterly 0.4 USD |
| 03/11/2021 | Quarterly 0.39 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 51 750 51 807 -0.11% | 41 908 48 014 -12.72% | 81 288 81 781 -0.6% | 100 330 100 373 -0.04% | 58 496 59 105 -1.03% | 59 955 |
|
EBITDA Million USD | Released Forecast Spread | 21 097 22 824 -7.57% | 17 801 21 398 -16.81% | 25 426 29 444 -13.65% | 42 336 44 597 -5.07% | 15 590 11 249 38.59% | 19 802 |
|
EBIT Million USD | Released Forecast Spread | 19 420 19 883 -2.33% | 13 024 17 362 -24.99% | 20 235 26 662 -24.11% | 37 272 40 403 -7.75% | 9 300 8 509 9.3% | 16 364 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 17 682 22 426 -21.15% | 7 497 13 166 -43.06% | 24 311 19 569 24.23% | 34 729 39 058 -11.08% | 1 058 2 301 -54.02% | 9 561 |
|
Net income Million USD | Released Forecast Spread | 16 273 19 053 -14.59% | 9 616 16 066 -40.15% | 21 979 22 567 -2.6% | 31 372 33 053 -5.09% | 2 119 3 040 -30.29% | 6 746 |
|
EPS USD | Released Forecast Spread | 2,87 3,40 -15.62% | 1,71 3,07 -44.24% | 3,85 3,89 -0.9% | 5,47 5,85 -6.45% | 0,37 0,72 -48.44% | 1,36 |
| Announcement Date | 28/01/20 | 02/02/21 | 08/02/22 | 31/01/23 | 30/01/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 23 838 24 203 -1.51% | 25 661 24 734 3.75% | 27 742 26 199 5.89% | 22 638 21 091 7.33% | 24 290 24 393 -0.42% | 18 282 16 488 10.88% | 12 734 13 398 -4.96% | 13 232 13 429 -1.47% | 14 249 14 396 -1.02% | 13 923 | 13 125 | 15 077 | 17 812 | 15 680 |
|
EBITDA Million USD | Released Forecast Spread | 4 403 6 196 -28.93% | 11 135 13 710 -18.78% | 13 583 12 434 9.25% | 10 325 10 332 -0.06% | 6 772 7 436 -8.92% | 7 857 7 513 4.58% | 4 925 4 000 23.13% | -1 244 -1 511 17.64% | 1 340 -1 298 203.24% | 4 403 | 4 127 | 5 359 | 4 754 | |
|
EBIT Million USD | Released Forecast Spread | 3 126 5 610 -44.28% | 9 948 9 738 2.16% | 12 408 11 055 12.24% | 9 142 9 092 0.55% | 5 253 6 886 -23.71% | 6 370 6 471 -1.56% | 3 319 3 634 -8.68% | -1 625 -1 827 11.07% | -330 -1 404 76.5% | 3 667 | 3 343 | 4 305 | 4 999 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9 050 | 5 231 7 425 -29.55% | -3 352 2 207 -251.88% | -4 129 -3 139 -31.54% | 2 992 | 2 061 | 2 651 | 3 182 | ||||||
|
Net income Million USD | Released Forecast Spread | 3 393 5 046 -32.75% | 7 864 8 418 -6.58% | 9 906 9 799 1.09% | 8 608 7 631 12.8% | 4 995 5 667 -11.86% | 5 543 4 495 23.31% | 2 327 | -2 382 -3 241 26.49% | -3 369 -2 371 -42.12% | 1 951 | 1 265 | 2 156 | 3 135 | |
|
EPS USD | Released Forecast Spread | 0,59 0,74 -20.27% | 1,37 1,60 -14.17% | 1,73 1,64 5.73% | 1,51 1,37 10.21% | 0,87 0,69 25.48% | 0,97 0,85 14.79% | 0,41 | -0,42 -0,51 16.83% | -0,60 -0,43 -41.06% | 0,34 | 0,23 | 0,43 | 0,55 | |
| Announcement Date | 08/02/22 | 03/05/22 | 28/07/22 | 01/11/22 | 31/01/23 | 02/05/23 | 01/08/23 | 31/10/23 | 30/01/24 | - | - | - | - | - |
More events
Past sector events for Pfizer, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PFE Stock
- Calendar Pfizer, Inc.
